Current treatment guidelines for topical corticosteroids
- PMID: 3076133
- DOI: 10.2165/00003495-198800365-00004
Current treatment guidelines for topical corticosteroids
Abstract
The effectiveness of a topical corticosteroid is related to various factors which should be considered when planning treatment. The most relevant factor is the potency of the drug. Another important factor is the absorption through the skin, which is influenced by marked regional variations in percutaneous penetration, hydration and the degree of inflammation present, types of dressings, the solubility of the drug and the age of the patient. Multiple daily applications do not lead to better or faster resolution of the disease. Intermittent therapy with treatment-free intervals, when the vehicle alone is applied, can be as effective as continuous treatment. The choice of a topical corticosteroid depends not only on the severity or activity of the disease, but also on the age of the subject, the body site affected and the extent of the surface area to be treated. In addition, the choice of vehicle depends on the type of lesion and on the body region afflicted. Combinations of a corticosteroid with other agents can be useful, but they are recommended in only a few specific indications. Treatment guidelines for topical corticosteroids must therefore take into account a number of factors which will influence the clinician's ultimate decision in providing care for the patient with steroid-responsive dermatoses.
Similar articles
-
Topical corticosteroids. Which drug and when?Drugs. 1992 Jul;44(1):65-71. doi: 10.2165/00003495-199244010-00006. Drugs. 1992. PMID: 1379911 Review.
-
Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review.Drugs. 1988;36 Suppl 5:51-61. doi: 10.2165/00003495-198800365-00011. Drugs. 1988. PMID: 3076132 Review.
-
A clinician's paradigm in the treatment of atopic dermatitis.J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S70-7. doi: 10.1016/j.jaad.2005.04.032. J Am Acad Dermatol. 2005. PMID: 15968266 Review.
-
Corticosteroids: options in the era of steroid-sparing therapy.J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. doi: 10.1016/j.jaad.2005.04.030. J Am Acad Dermatol. 2005. PMID: 15968264 Review.
-
Clinical potential of topical corticosteroids.Drugs. 1988;36 Suppl 5:38-42. doi: 10.2165/00003495-198800365-00008. Drugs. 1988. PMID: 3076130 Review.
Cited by
-
Topical corticosteroids. Which drug and when?Drugs. 1992 Jul;44(1):65-71. doi: 10.2165/00003495-199244010-00006. Drugs. 1992. PMID: 1379911 Review.
-
Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.Drug Saf. 1994 May;10(5):406-12. doi: 10.2165/00002018-199410050-00005. Drug Saf. 1994. PMID: 8037890 Review.
-
Kyrle disease: a systematic review of clinical features, diagnostic approaches, dermatoscopic insights, systemic associations, and therapeutic strategies.Arch Dermatol Res. 2025 Mar 23;317(1):622. doi: 10.1007/s00403-025-04067-4. Arch Dermatol Res. 2025. PMID: 40121580
-
Systematic review of Flegel disease: clinical presentations, associations, diagnostic pitfalls, and management challenges.Arch Dermatol Res. 2025 May 16;317(1):766. doi: 10.1007/s00403-025-04268-x. Arch Dermatol Res. 2025. PMID: 40380040 Review.
-
Ethical use of topical corticosteroids.Indian J Dermatol. 2014 Sep;59(5):469-72. doi: 10.4103/0019-5154.139877. Indian J Dermatol. 2014. PMID: 25284852 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical